New York University Abu Dhabi deploys MBioLIMS BioBanking® software for long-term public health study of 20,000 UAE Nationals
2 June 2016
Logo RARENET Complet
The European project RARENET acquires MBioLIMS®
22 June 2017
Show all

IMODI published its first newsletter on its new website

The french IMODI (Innovative MODels Initiative) consortium is dedicated to the development, the characterization and the commercialization of new preclinical models in oncology. This newsletter No. 1 zoom on the microbiota and cancer with a new website, posters and Biofortis innovation services.Discover and share the Newsletter IMODI #1 July 2016.